Moderate riskFDA DeviceClass II

Merge OrthoPACS workstation recalled for possible image display error

Merge Healthcare's OrthoPACS medical imaging workstation may show thumbnails from a previously opened patient study while a different patient study is open. The recall covers 5 units distributed in the US, Canada and the UK. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check whether your OrthoPACS software is version 9.4, 9.4 P01 or 9.4 P02, with UDI/DI 00842000101154.
  2. Contact Merge Healthcare for guidance on the affected versions. The notice does not specify a remedy.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Merge OrthoPACS, medical imaging diagnostic workstation
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
5 units
Illnesses reported
None reported
Manufactured in
900 Walnut Ridge Dr, Hartland, WI, United States
Classification
Class II
Recall number
Z-2875-2026

In the FDA's words

Description
Merge OrthoPACS, medical imaging diagnostic workstation Thumbnails from a previously opened patient study may be displayed in the Thumbnail Bar while a different patient study is currently open. UDI/DI (01)00842000101154(10)9.4.0.P02(11)260302, with Affected Versions: 9.4, 9.4 P01, and 9.4 P02. Distribution: Worldwide distribution - US Nationwide and the countries of Canada, and UK. Affected quantity: 5 units
Hazard
Thumbnails from a previously opened patient study may be displayed in the Thumbnail Bar while a different patient study is currently open.

2 products in this recall

Merge PACS and OrthoPACS workstations recalled for thumbnail display risk

Merge Healthcare is recalling 58 imaging workstations in two products: 53 units of Merge PACS and 5 units of Merge OrthoPACS. Thumbnails from a previously opened patient study may appear in the Thumbnail Bar while a different patient study is open. The FDA classified the recall as Class II. The notice reports no injuries. It covers US nationwide distribution and Canada and the UK.

The agency lists each product separately. Check every one you might have.

More from Merge Healthcare

Related topics

OtherSoftwareMedical devicesSold nationwideMore from FDA Device